TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2016 DA - 2016// TI - Cancer statistics, 2016 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21332 DO - 10.3322/caac.21332 ID - Siegel2016 ER - TY - JOUR AU - Llovet, J. M. AU - Ricci, S. AU - Mazzaferro, V. AU - Hilgard, P. AU - Gane, E. AU - Blanc, J. F. PY - 2008 DA - 2008// TI - Sorafenib in advanced hepatocellular carcinoma JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0708857 DO - 10.1056/NEJMoa0708857 ID - Llovet2008 ER - TY - JOUR AU - Bruix, J. AU - Qin, S. AU - Merle, P. AU - Granito, A. AU - Huang, Y. H. AU - Bodoky, G. PY - 2017 DA - 2017// TI - Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial JO - Lancet. VL - 389 UR - https://doi.org/10.1016/S0140-6736(16)32453-9 DO - 10.1016/S0140-6736(16)32453-9 ID - Bruix2017 ER - TY - JOUR AU - Fruman, D. A. AU - Rommel, C. PY - 2014 DA - 2014// TI - PI3K and cancer: lessons, challenges and opportunities JO - Nat Rev Drug Discov VL - 13 UR - https://doi.org/10.1038/nrd4204 DO - 10.1038/nrd4204 ID - Fruman2014 ER - TY - JOUR AU - Thorpe, L. M. AU - Yuzugullu, H. AU - Zhao, J. J. PY - 2015 DA - 2015// TI - PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc3860 DO - 10.1038/nrc3860 ID - Thorpe2015 ER - TY - JOUR AU - Matter, M. S. AU - Decaens, T. AU - Andersen, J. B. AU - Thorgeirsson, S. S. PY - 2014 DA - 2014// TI - Targeting the mTOR pathway in hepatocellular carcinoma: current state and future trends JO - J Hepatol VL - 60 UR - https://doi.org/10.1016/j.jhep.2013.11.031 DO - 10.1016/j.jhep.2013.11.031 ID - Matter2014 ER - TY - JOUR AU - Polivka, J. AU - Janku, F. PY - 2014 DA - 2014// TI - Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway JO - Pharmacol Ther VL - 142 UR - https://doi.org/10.1016/j.pharmthera.2013.12.004 DO - 10.1016/j.pharmthera.2013.12.004 ID - Polivka2014 ER - TY - JOUR AU - Li, J. AU - Yen, C. AU - Liaw, D. AU - Podsypanina, K. AU - Bose, S. AU - Wang, S. I. PY - 1997 DA - 1997// TI - PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer JO - Science. VL - 275 UR - https://doi.org/10.1126/science.275.5308.1943 DO - 10.1126/science.275.5308.1943 ID - Li1997 ER - TY - JOUR PY - 2017 DA - 2017// TI - Electronic address wbe, Cancer genome atlas research N. Comprehensive and integrative genomic characterization of hepatocellular carcinoma JO - Cell. VL - 169 UR - https://doi.org/10.1016/j.cell.2017.05.046 DO - 10.1016/j.cell.2017.05.046 ID - ref9 ER - TY - JOUR AU - Bruhn, M. A. AU - Pearson, R. B. AU - Hannan, R. D. AU - Sheppard, K. E. PY - 2010 DA - 2010// TI - Second AKT: the rise of SGK in cancer signalling JO - Growth factors (Chur, Switzerland) VL - 28 UR - https://doi.org/10.3109/08977194.2010.518616 DO - 10.3109/08977194.2010.518616 ID - Bruhn2010 ER - TY - JOUR AU - Scortegagna, M. AU - Lau, E. AU - Zhang, T. AU - Feng, Y. AU - Sereduk, C. AU - Yin, H. PY - 2015 DA - 2015// TI - PDK1 and SGK3 contribute to the growth of BRAF-mutant melanomas and are potential therapeutic targets JO - Cancer Res VL - 75 UR - https://doi.org/10.1158/0008-5472.can-14-2785 DO - 10.1158/0008-5472.can-14-2785 ID - Scortegagna2015 ER - TY - JOUR AU - Lang, F. AU - Bohmer, C. AU - Palmada, M. AU - Seebohm, G. AU - Strutz-Seebohm, N. AU - Vallon, V. PY - 2006 DA - 2006// TI - (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms JO - Physiol Rev VL - 86 UR - https://doi.org/10.1152/physrev.00050.2005 DO - 10.1152/physrev.00050.2005 ID - Lang2006 ER - TY - JOUR AU - Wang, Y. u. a. n. z. h. o. n. g. AU - Zhou, D. u. j. i. n. AU - Chen, S. h. i. u. a. n. PY - 2014 DA - 2014// TI - SGK3 Is an Androgen-Inducible Kinase Promoting Prostate Cancer Cell Proliferation Through Activation of p70 S6 Kinase and Up-Regulation of Cyclin D1 JO - Molecular Endocrinology VL - 28 UR - https://doi.org/10.1210/me.2013-1339 DO - 10.1210/me.2013-1339 ID - Wang2014 ER - TY - JOUR AU - Gasser, J. A. AU - Inuzuka, H. AU - Lau, A. W. AU - Wei, W. AU - Beroukhim, R. AU - Toker, A. PY - 2014 DA - 2014// TI - SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer JO - Mol Cell VL - 56 UR - https://doi.org/10.1016/j.molcel.2014.09.023 DO - 10.1016/j.molcel.2014.09.023 ID - Gasser2014 ER - TY - JOUR AU - Liu, M. AU - Chen, L. AU - Chan, T. H. AU - Wang, J. AU - Li, Y. AU - Li, Y. PY - 2012 DA - 2012// TI - Serum and glucocorticoid kinase 3 at 8q13.1 promotes cell proliferation and survival in hepatocellular carcinoma JO - Hepatology. VL - 55 UR - https://doi.org/10.1002/hep.25584 DO - 10.1002/hep.25584 ID - Liu2012 ER - TY - JOUR AU - Liu, F. AU - Wu, X. AU - Jiang, X. AU - Qian, Y. AU - Gao, J. PY - 2018 DA - 2018// TI - Prolonged inhibition of class I PI3K promotes liver cancer stem cell expansion by augmenting SGK3/GSK-3beta/beta-catenin signalling JO - J Exp Clin Cancer Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0801-8 DO - 10.1186/s13046-018-0801-8 ID - Liu2018 ER - TY - JOUR AU - Stemke-Hale, K. AU - Gonzalez-Angulo, A. M. AU - Lluch, A. AU - Neve, R. M. AU - Kuo, W. L. AU - Davies, M. PY - 2008 DA - 2008// TI - An integrative genomic and proteomic analysis of PIK3CA, PTEN, and AKT mutations in breast cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-6854 DO - 10.1158/0008-5472.CAN-07-6854 ID - Stemke-Hale2008 ER - TY - JOUR AU - Vasudevan, K. M. AU - Barbie, D. A. AU - Davies, M. A. AU - Rabinovsky, R. AU - McNear, C. J. AU - Kim, J. J. PY - 2009 DA - 2009// TI - AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer JO - Cancer Cell VL - 16 UR - https://doi.org/10.1016/j.ccr.2009.04.012 DO - 10.1016/j.ccr.2009.04.012 ID - Vasudevan2009 ER - TY - JOUR AU - Takiar, V. AU - Ip, C. K. AU - Gao, M. AU - Mills, G. B. AU - Cheung, L. W. PY - 2017 DA - 2017// TI - Neomorphic mutations create therapeutic challenges in cancer JO - Oncogene. VL - 36 UR - https://doi.org/10.1038/onc.2016.312 DO - 10.1038/onc.2016.312 ID - Takiar2017 ER - TY - JOUR AU - Wang, C. AU - Che, L. AU - Hu, J. AU - Zhang, S. AU - Jiang, L. AU - Latte, G. PY - 2016 DA - 2016// TI - Activated mutant forms of PIK3CA cooperate with RasV12 or c-met to induce liver tumour formation in mice via AKT2/mTORC1 cascade JO - Liver Int VL - 36 UR - https://doi.org/10.1111/liv.13055 DO - 10.1111/liv.13055 ID - Wang2016 ER - TY - JOUR AU - Xu, Z. AU - Hu, J. AU - Cao, H. AU - Pilo, M. G. AU - Cigliano, A. AU - Shao, Z. PY - 2018 DA - 2018// TI - Loss of Pten synergizes with c-met to promote hepatocellular carcinoma development via mTORC2 pathway JO - Exp Mol Med VL - 50 UR - https://doi.org/10.1038/emm.2017.158 DO - 10.1038/emm.2017.158 ID - Xu2018 ER - TY - JOUR AU - Galicia, V. A. AU - He, L. AU - Dang, H. AU - Kanel, G. AU - Vendryes, C. AU - French, B. A. PY - 2010 DA - 2010// TI - Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2 JO - Gastroenterology. VL - 139 UR - https://doi.org/10.1053/j.gastro.2010.09.002 DO - 10.1053/j.gastro.2010.09.002 ID - Galicia2010 ER - TY - JOUR AU - Li, L. AU - Che, L. AU - Tharp, K. M. AU - Park, H. M. AU - Pilo, M. G. AU - Cao, D. PY - 2016 DA - 2016// TI - Differential requirement for de novo lipogenesis in cholangiocarcinoma and hepatocellular carcinoma of mice and humans JO - Hepatology. VL - 63 UR - https://doi.org/10.1002/hep.28508 DO - 10.1002/hep.28508 ID - Li2016 ER - TY - JOUR AU - Hu, J. AU - Che, L. AU - Li, L. AU - Pilo, M. G. AU - Cigliano, A. AU - Ribback, S. PY - 2016 DA - 2016// TI - Co-activation of AKT and c-met triggers rapid hepatocellular carcinoma development via the mTORC1/FASN pathway in mice JO - Sci Rep VL - 6 UR - https://doi.org/10.1038/srep20484 DO - 10.1038/srep20484 ID - Hu2016 ER - TY - JOUR AU - Xue, W. AU - Chen, S. AU - Yin, H. AU - Tammela, T. AU - Papagiannakopoulos, T. AU - Joshi, N. S. PY - 2014 DA - 2014// TI - CRISPR-mediated direct mutation of cancer genes in the mouse liver JO - Nature. VL - 514 UR - https://doi.org/10.1038/nature13589 DO - 10.1038/nature13589 ID - Xue2014 ER - TY - JOUR AU - McCormick, J. A. AU - Feng, Y. AU - Dawson, K. AU - Behne, M. J. AU - Yu, B. AU - Wang, J. PY - 2004 DA - 2004// TI - Targeted disruption of the protein kinase SGK3/CISK impairs postnatal hair follicle development JO - Mol Biol Cell VL - 15 UR - https://doi.org/10.1091/mbc.E04-01-0027 DO - 10.1091/mbc.E04-01-0027 ID - McCormick2004 ER - TY - JOUR AU - Chen, X. AU - Calvisi, D. F. PY - 2014 DA - 2014// TI - Hydrodynamic transfection for generation of novel mouse models for liver cancer research JO - Am J Pathol VL - 184 UR - https://doi.org/10.1016/j.ajpath.2013.12.002 DO - 10.1016/j.ajpath.2013.12.002 ID - Chen2014 ER - TY - JOUR AU - Delogu, S. AU - Wang, C. AU - Cigliano, A. AU - Utpatel, K. AU - Sini, M. AU - Longerich, T. PY - 2015 DA - 2015// TI - SKP2 cooperates with N-Ras or AKT to induce liver tumor development in mice JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.2945 DO - 10.18632/oncotarget.2945 ID - Delogu2015 ER - TY - JOUR AU - Calvisi, D. F. AU - Wang, C. AU - Ho, C. AU - Ladu, S. AU - Lee, S. A. AU - Mattu, S. PY - 2011 DA - 2011// TI - Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma JO - Gastroenterology. VL - 140 UR - https://doi.org/10.1053/j.gastro.2010.12.006 DO - 10.1053/j.gastro.2010.12.006 ID - Calvisi2011 ER - TY - JOUR AU - Wu, M. AU - Huang, C. AU - Huang, X. AU - Liang, R. AU - Feng, Y. AU - Luo, X. PY - 2017 DA - 2017// TI - MicroRNA-144-3p suppresses tumor growth and angiogenesis by targeting SGK3 in hepatocellular carcinoma JO - Oncol Rep VL - 38 UR - https://doi.org/10.3892/or.2017.5900 DO - 10.3892/or.2017.5900 ID - Wu2017 ER - TY - JOUR AU - Liu, J. AU - Zhang, G. AU - Lv, Y. AU - Zhang, X. AU - Ying, C. AU - Yang, S. PY - 2017 DA - 2017// TI - SGK2 promotes hepatocellular carcinoma progression and mediates GSK-3beta/beta-catenin signaling in HCC cells JO - Tumour biol VL - 39 UR - https://doi.org/10.1177/1010428317700408 DO - 10.1177/1010428317700408 ID - Liu2017 ER - TY - JOUR AU - Kong, X. AU - Liu, F. AU - Gao, J. PY - 2016 DA - 2016// TI - MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/beta-catenin signaling pathways JO - Oncotarget. VL - 7 UR - https://doi.org/10.18632/oncotarget.11800 DO - 10.18632/oncotarget.11800 ID - Kong2016 ER - TY - JOUR AU - Cadoret, A. AU - Ovejero, C. AU - Terris, B. AU - Souil, E. AU - Levy, L. AU - Lamers, W. H. PY - 2002 DA - 2002// TI - New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism JO - Oncogene. VL - 21 UR - https://doi.org/10.1038/sj.onc.1206118 DO - 10.1038/sj.onc.1206118 ID - Cadoret2002 ER - TY - JOUR AU - Bruhn, M. A. AU - Pearson, R. B. AU - Hannan, R. D. AU - Sheppard, K. E. PY - 2013 DA - 2013// TI - AKT-independent PI3-K signaling in cancer - emerging role for SGK3 JO - Cancer Manag Res VL - 5 UR - https://doi.org/10.2147/cmar.s35178 DO - 10.2147/cmar.s35178 ID - Bruhn2013 ER - TY - JOUR AU - Sun, X. AU - Liu, X. AU - Liu, B. O. AU - Li, S. AU - Zhang, D. AU - Guo, H. PY - 2016 DA - 2016// TI - Serum- and glucocorticoid-regulated protein kinase 3 overexpression promotes tumor development and aggression in breast cancer cells JO - Oncol Lett VL - 12 UR - https://doi.org/10.3892/ol.2016.4638 DO - 10.3892/ol.2016.4638 ID - Sun2016 ER - TY - JOUR AU - Guo, S. T. AU - Chi, M. N. AU - Yang, R. H. AU - Guo, X. Y. AU - Zan, L. K. AU - Wang, C. Y. PY - 2016 DA - 2016// TI - INPP4B is an oncogenic regulator in human colon cancer JO - Oncogene. VL - 35 UR - https://doi.org/10.1038/onc.2015.361 DO - 10.1038/onc.2015.361 ID - Guo2016 ER - TY - JOUR AU - Wang, Y. AU - Zhou, D. AU - Phung, S. AU - Masri, S. AU - Smith, D. AU - Chen, S. PY - 2011 DA - 2011// TI - SGK3 is an estrogen-inducible kinase promoting estrogen-mediated survival of breast cancer cells JO - Molecular endocrinology (Baltimore, Md) VL - 25 UR - https://doi.org/10.1210/me.2010-0294 DO - 10.1210/me.2010-0294 ID - Wang2011 ER -